Industry: Medical Devices & Consumables
Published Date: 2025-01-16
Pages: 159 Pages
Report ld: 3474010
Request Sample
Customized Report
Hemostatic Forceps Market Size(US$)

CAGR 2025-2031
4.3%
Market Size,2031
USD 87.2
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hemostatic Forceps was estimated to be worth US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.
Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.
In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Forceps, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hemostatic Forceps by region & country, by Type, and by Application.
The Hemostatic Forceps market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Forceps.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hemostatic Forceps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hemostatic Forceps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hemostatic Forceps in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hemostatic Forceps Product Introduction
1.2 Global Hemostatic Forceps Market Size Forecast
1.2.1 Global Hemostatic Forceps Sales Value (2020-2031)
1.2.2 Global Hemostatic Forceps Sales Volume (2020-2031)
1.2.3 Global Hemostatic Forceps Sales Price (2020-2031)
1.3 Hemostatic Forceps Market Trends & Drivers
1.3.1 Hemostatic Forceps Industry Trends
1.3.2 Hemostatic Forceps Market Drivers & Opportunity
1.3.3 Hemostatic Forceps Market Challenges
1.3.4 Hemostatic Forceps Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hemostatic Forceps Players Revenue Ranking (2024)
2.2 Global Hemostatic Forceps Revenue by Company (2020-2025)
2.3 Global Hemostatic Forceps Players Sales Volume Ranking (2024)
2.4 Global Hemostatic Forceps Sales Volume by Company Players (2020-2025)
2.5 Global Hemostatic Forceps Average Price by Company (2020-2025)
2.6 Key Manufacturers Hemostatic Forceps Manufacturing Base and Headquarters
2.7 Key Manufacturers Hemostatic Forceps Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hemostatic Forceps
2.9 Hemostatic Forceps Market Competitive Analysis
2.9.1 Hemostatic Forceps Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Hemostatic Forceps Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Forceps as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Halstead Mosquito Hemostatic Forceps
3.1.2 Kelly and Crile Hemostatic Forceps
3.1.3 Rochester-Carmalt Hemostatic Forceps
3.2 Global Hemostatic Forceps Sales Value by Type
3.2.1 Global Hemostatic Forceps Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Hemostatic Forceps Sales Value, by Type (2020-2031)
3.2.3 Global Hemostatic Forceps Sales Value, by Type (%) (2020-2031)
3.3 Global Hemostatic Forceps Sales Volume by Type
3.3.1 Global Hemostatic Forceps Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Hemostatic Forceps Sales Volume, by Type (2020-2031)
3.3.3 Global Hemostatic Forceps Sales Volume, by Type (%) (2020-2031)
3.4 Global Hemostatic Forceps Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Surgical
4.1.2 Dissection
4.1.3 Dental
4.1.4 Laparoscopic
4.1.5 Others
4.2 Global Hemostatic Forceps Sales Value by Application
4.2.1 Global Hemostatic Forceps Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Hemostatic Forceps Sales Value, by Application (2020-2031)
4.2.3 Global Hemostatic Forceps Sales Value, by Application (%) (2020-2031)
4.3 Global Hemostatic Forceps Sales Volume by Application
4.3.1 Global Hemostatic Forceps Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Hemostatic Forceps Sales Volume, by Application (2020-2031)
4.3.3 Global Hemostatic Forceps Sales Volume, by Application (%) (2020-2031)
4.4 Global Hemostatic Forceps Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Hemostatic Forceps Sales Value by Region
5.1.1 Global Hemostatic Forceps Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Hemostatic Forceps Sales Value by Region (2020-2025)
5.1.3 Global Hemostatic Forceps Sales Value by Region (2026-2031)
5.1.4 Global Hemostatic Forceps Sales Value by Region (%), (2020-2031)
5.2 Global Hemostatic Forceps Sales Volume by Region
5.2.1 Global Hemostatic Forceps Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Hemostatic Forceps Sales Volume by Region (2020-2025)
5.2.3 Global Hemostatic Forceps Sales Volume by Region (2026-2031)
5.2.4 Global Hemostatic Forceps Sales Volume by Region (%), (2020-2031)
5.3 Global Hemostatic Forceps Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Hemostatic Forceps Sales Value, 2020-2031
5.4.2 North America Hemostatic Forceps Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Hemostatic Forceps Sales Value, 2020-2031
5.5.2 Europe Hemostatic Forceps Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Hemostatic Forceps Sales Value, 2020-2031
5.6.2 Asia Pacific Hemostatic Forceps Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Hemostatic Forceps Sales Value, 2020-2031
5.7.2 South America Hemostatic Forceps Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hemostatic Forceps Sales Value, 2020-2031
5.8.2 Middle East & Africa Hemostatic Forceps Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hemostatic Forceps Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Hemostatic Forceps Sales Value
6.2.1 Key Countries/Regions Hemostatic Forceps Sales Value, 2020-2031
6.2.2 Key Countries/Regions Hemostatic Forceps Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Hemostatic Forceps Sales Value, 2020-2031
6.3.2 United States Hemostatic Forceps Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Hemostatic Forceps Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Hemostatic Forceps Sales Value, 2020-2031
6.4.2 Europe Hemostatic Forceps Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Hemostatic Forceps Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Hemostatic Forceps Sales Value, 2020-2031
6.5.2 China Hemostatic Forceps Sales Value by Type (%), 2024 VS 2031
6.5.3 China Hemostatic Forceps Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Hemostatic Forceps Sales Value, 2020-2031
6.6.2 Japan Hemostatic Forceps Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Hemostatic Forceps Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Hemostatic Forceps Sales Value, 2020-2031
6.7.2 South Korea Hemostatic Forceps Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Hemostatic Forceps Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Hemostatic Forceps Sales Value, 2020-2031
6.8.2 Southeast Asia Hemostatic Forceps Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Hemostatic Forceps Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Hemostatic Forceps Sales Value, 2020-2031
6.9.2 India Hemostatic Forceps Sales Value by Type (%), 2024 VS 2031
6.9.3 India Hemostatic Forceps Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Medline
7.1.1 Medline Company Information
7.1.2 Medline Introduction and Business Overview
7.1.3 Medline Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Medline Hemostatic Forceps Product Offerings
7.1.5 Medline Recent Development
7.2 B. Braun
7.2.1 B. Braun Company Information
7.2.2 B. Braun Introduction and Business Overview
7.2.3 B. Braun Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 B. Braun Hemostatic Forceps Product Offerings
7.2.5 B. Braun Recent Development
7.3 CareFusion
7.3.1 CareFusion Company Information
7.3.2 CareFusion Introduction and Business Overview
7.3.3 CareFusion Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 CareFusion Hemostatic Forceps Product Offerings
7.3.5 CareFusion Recent Development
7.4 Asa Dental
7.4.1 Asa Dental Company Information
7.4.2 Asa Dental Introduction and Business Overview
7.4.3 Asa Dental Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Asa Dental Hemostatic Forceps Product Offerings
7.4.5 Asa Dental Recent Development
7.5 Sklar
7.5.1 Sklar Company Information
7.5.2 Sklar Introduction and Business Overview
7.5.3 Sklar Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Sklar Hemostatic Forceps Product Offerings
7.5.5 Sklar Recent Development
7.6 Scanlan International
7.6.1 Scanlan International Company Information
7.6.2 Scanlan International Introduction and Business Overview
7.6.3 Scanlan International Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Scanlan International Hemostatic Forceps Product Offerings
7.6.5 Scanlan International Recent Development
7.7 Shanghai Medical Instruments
7.7.1 Shanghai Medical Instruments Company Information
7.7.2 Shanghai Medical Instruments Introduction and Business Overview
7.7.3 Shanghai Medical Instruments Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Shanghai Medical Instruments Hemostatic Forceps Product Offerings
7.7.5 Shanghai Medical Instruments Recent Development
7.8 Lawton
7.8.1 Lawton Company Information
7.8.2 Lawton Introduction and Business Overview
7.8.3 Lawton Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Lawton Hemostatic Forceps Product Offerings
7.8.5 Lawton Recent Development
7.9 Hu-Friedy
7.9.1 Hu-Friedy Company Information
7.9.2 Hu-Friedy Introduction and Business Overview
7.9.3 Hu-Friedy Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Hu-Friedy Hemostatic Forceps Product Offerings
7.9.5 Hu-Friedy Recent Development
7.10 Xinhua Surgical
7.10.1 Xinhua Surgical Company Information
7.10.2 Xinhua Surgical Introduction and Business Overview
7.10.3 Xinhua Surgical Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Xinhua Surgical Hemostatic Forceps Product Offerings
7.10.5 Xinhua Surgical Recent Development
7.11 Towne Brothers
7.11.1 Towne Brothers Company Information
7.11.2 Towne Brothers Introduction and Business Overview
7.11.3 Towne Brothers Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Towne Brothers Hemostatic Forceps Product Offerings
7.11.5 Towne Brothers Recent Development
7.12 Teleflex Medical
7.12.1 Teleflex Medical Company Information
7.12.2 Teleflex Medical Introduction and Business Overview
7.12.3 Teleflex Medical Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Teleflex Medical Hemostatic Forceps Product Offerings
7.12.5 Teleflex Medical Recent Development
7.13 Delacroix Chevalier
7.13.1 Delacroix Chevalier Company Information
7.13.2 Delacroix Chevalier Introduction and Business Overview
7.13.3 Delacroix Chevalier Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Delacroix Chevalier Hemostatic Forceps Product Offerings
7.13.5 Delacroix Chevalier Recent Development
7.14 YDM
7.14.1 YDM Company Information
7.14.2 YDM Introduction and Business Overview
7.14.3 YDM Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 YDM Hemostatic Forceps Product Offerings
7.14.5 YDM Recent Development
7.15 M A Corporation
7.15.1 M A Corporation Company Information
7.15.2 M A Corporation Introduction and Business Overview
7.15.3 M A Corporation Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 M A Corporation Hemostatic Forceps Product Offerings
7.15.5 M A Corporation Recent Development
7.16 MedGyn Products
7.16.1 MedGyn Products Company Information
7.16.2 MedGyn Products Introduction and Business Overview
7.16.3 MedGyn Products Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 MedGyn Products Hemostatic Forceps Product Offerings
7.16.5 MedGyn Products Recent Development
7.17 Inami
7.17.1 Inami Company Information
7.17.2 Inami Introduction and Business Overview
7.17.3 Inami Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Inami Hemostatic Forceps Product Offerings
7.17.5 Inami Recent Development
7.18 Ted Pella
7.18.1 Ted Pella Company Information
7.18.2 Ted Pella Introduction and Business Overview
7.18.3 Ted Pella Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Ted Pella Hemostatic Forceps Product Offerings
7.18.5 Ted Pella Recent Development
7.19 Medicon eG
7.19.1 Medicon eG Company Information
7.19.2 Medicon eG Introduction and Business Overview
7.19.3 Medicon eG Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Medicon eG Hemostatic Forceps Product Offerings
7.19.5 Medicon eG Recent Development
7.20 J & J Instruments
7.20.1 J & J Instruments Company Information
7.20.2 J & J Instruments Introduction and Business Overview
7.20.3 J & J Instruments Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 J & J Instruments Hemostatic Forceps Product Offerings
7.20.5 J & J Instruments Recent Development
7.21 American Diagnostic
7.21.1 American Diagnostic Company Information
7.21.2 American Diagnostic Introduction and Business Overview
7.21.3 American Diagnostic Hemostatic Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 American Diagnostic Hemostatic Forceps Product Offerings
7.21.5 American Diagnostic Recent Development
8 Industry Chain Analysis
8.1 Hemostatic Forceps Industrial Chain
8.2 Hemostatic Forceps Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hemostatic Forceps Sales Model
8.5.2 Sales Channel
8.5.3 Hemostatic Forceps Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Hemostatic Forceps market size was US$ 67.75 million in 2025 and is forecast to reach a readjusted size of US$ 90.6 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 115
USD 4250.00
(Single User License)
The global Hemostatic Forceps market was valued at US$ 67.75 million in 2025 and is anticipated to reach US$ 90.6 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 138
USD 2900.00
(Single User License)
The global market for Hemostatic Forceps was estimated to be worth US$ 67.75 million in 2025 and is projected to reach US$ 90.6 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 163
USD 3950.00
(Single User License)
The global Hemostatic Forceps market is projected to grow from US$ 65.2 million in 2024 to US$ 87.2 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 200
USD 4900.00
(Single User License)
In 2024, the global market size of Hemostatic Forceps was estimated to be worth US$ 65.2 million and is forecast to reach approximately US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 181
USD 5900.00
(Single User License)
The global Hemostatic Forceps market size was US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 111
USD 4250.00
(Single User License)
The global market for Hemostatic Forceps was valued at US$ 65.2 million in the year 2024 and is projected to reach a revised size of US$ 87.2 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-01-16
Pages: 117
USD 2900.00
(Single User License)
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-17
Pages: 207
USD 5600.00
(Single User License)
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-16
Pages: 186
USD 5900.00
(Single User License)
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-07
Pages: 129
USD 4900.00
(Single User License)
The global Hemostatic Forceps market size was US$ 67.75 million in 2025 and is forecast to reach a readjusted size of US$ 90.6 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 115
The global Hemostatic Forceps market was valued at US$ 67.75 million in 2025 and is anticipated to reach US$ 90.6 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 138
The global market for Hemostatic Forceps was estimated to be worth US$ 67.75 million in 2025 and is projected to reach US$ 90.6 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 163
The global Hemostatic Forceps market is projected to grow from US$ 65.2 million in 2024 to US$ 87.2 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 200
In 2024, the global market size of Hemostatic Forceps was estimated to be worth US$ 65.2 million and is forecast to reach approximately US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 181
The global Hemostatic Forceps market size was US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 111
The global market for Hemostatic Forceps was valued at US$ 65.2 million in the year 2024 and is projected to reach a revised size of US$ 87.2 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-01-16
Pages: 117
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-17
Pages: 207
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-16
Pages: 186
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-07
Pages: 129
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now